NE
NEWUF.US Newtopia Inc
- Market cap
- USD 86.6K
- P/E
- -
- P/B
- 84.22x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is NEWUF.US undervalued?
Graham numberThe Graham number of Newtopia Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Newtopia Inc fundamental analysis
No fundamental analysis for Newtopia Inc yet.
Newtopia Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Newtopia Inc
Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.
Full company profileNewtopia Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Newtopia Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.50M | 3.07M | 6.11M | 11.4M | 10.5M | 11.2M | 9.78M | 5.83M |
| Gross Profit | 206K | 899K | 1.97M | 5.50M | 5.07M | 6.03M | 5.28M | 2.68M |
| Operating Income | -8.47M | -5.86M | -7.74M | -6.59M | -6.96M | -6.22M | -2.59M | -3.44M |
| EBITDA | -8.44M | -5.36M | -7.50M | -6.59M | -7.21M | -6.15M | -1.76M | -3.97M |
| Net Income | -7.70M | -6.39M | -10.1M | -7.73M | -7.65M | -7.70M | -6.60M | -5.37M |
| EPS | -0.12 | -0.07 | -0.16 | -0.12 | -0.08 | -0.07 | -0.04 | -0.03 |
| Balance Sheet | ||||||||
| Total Assets | 2.48M | 3.68M | 5.63M | 7.90M | 5.51M | 5.94M | 2.33M | 665K |
| Total Liabilities | 8.86M | 16.1M | 16.8M | 3.70M | 7.35M | 11.5M | 11.8M | 13.6M |
| Shareholders' Equity | -6.38M | -12.4M | -11.2M | 4.20M | -1.84M | -5.53M | -9.42M | -13.0M |
| Cash & Short-term Investments | 1.44M | 1.43M | 2.39M | 4.67M | 812K | 346K | 387K | 10.2K |
| Total Debt | 7.42M | 5.13M | 12.5M | 883K | 5.18M | 8.85M | 9.88M | 10.8M |
| Cash Flow | ||||||||
| Operating Cash Flow | -7.44M | -5.35M | -5.53M | -4.79M | -5.95M | -5.92M | -2.27M | -1.63M |
| Capital Expenditure | 59.7K | 42.3K | 163K | 92.8K | 2.15M | 989K | 2.55K | 4.00 |
| Free Cash Flow | -7.50M | -5.39M | -5.70M | -4.88M | -8.10M | -6.90M | -2.27M | -1.63M |
| Ratios | ||||||||
| ROE | - | - | - | -184.1% | - | - | - | - |
| ROA | -310.4% | -173.5% | -180.2% | -97.9% | -138.9% | -129.5% | -282.9% | -808.1% |
| Net Profit Margin | -512.2% | -207.8% | -166.0% | -67.7% | -73.2% | -69.0% | -67.5% | -92.2% |
| Debt to Equity | - | - | - | 0.21x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Newtopia Inc dividends
Newtopia Inc has not paid dividends in the last 7 fiscal years.
Who owns Newtopia Inc
Ownership data of Newtopia Inc is not available yet.
Newtopia Inc company profile
- Company name
- Newtopia Inc
- Ticker
- NEWUF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- 33 Bloor Street East, Toronto, ON, Canada, M4W 3H1
- Phone
- 888 639 8181
- Website
- newtopia.com
About Newtopia Inc
Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.
Newtopia Inc management
10- Mr. Jeffrey Ruby J.D.Founder, CEO & Chairman · born 1975
- Mr. Collin SwensonChief Financial Officer
- Mr. Peter SeiderChief Information, Privacy & Security Officer · born 1969
- Barclay JacksonSr. Marketing Office Executive
- Dr. Karyn Hood C. Psych, Ph.D.Head of Behavioral & Mental Health
- Ms. Rikki BennieSenior Vice President · born 1954
- Mr. Mark JacksonSenior Vice President of Commercial
- Mr. Louis Perusse Ph.D.Head of Genetics
- Mr. Leonard FensterheimSenior Vice President of Outcomes, Analytics & Reporting
- Mr. Gilles Lapointe Ph.D.Head of Genetics